# Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

> **NCT04107051** · — · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 533 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Nalmefene Hydrochloride Hydrate

## Key facts

- **NCT ID:** NCT04107051
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2023-02-07
- **Final completion:** 2024-02-06
- **Target enrollment:** 533 (ACTUAL)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04107051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04107051, "Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04107051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*